Approximately 60% of individuals with schizophrenia do not take their antipsychotic
medications as prescribed, and nonadherence is associated with exacerbation of psychotic …

Objective: To assess the extent to which ceasing the use of cannabis or other substances
reduces the symptoms and social disability associated with psychotic illness. Methods: The …

Background Nonadherence is common among patients with schizophrenia, although the
rates vary according to means of assessment and patient population. Failure to adhere to …

Nonadherence is the Achilles' heel of effective psychiatric treatment. It affects the resolution
of mental health symptoms and interferes with the assessment of treatment response. The …

As second‐generation antipsychotic long‐acting injections (SGA‐LAI s) are rapidly
replacing depot first‐generation antipsychotics as first‐line agents in treating schizophrenia …

Objective There have been few recent studies reporting on the outcomes for users of
psychiatric rehabilitation services. This group has complex, longer-term mental health …

Introduction Comorbid substance abuse is known to blunt response to treatment for
underlying psychiatric disorders, but it has not been investigated in schizophrenia when …

Medication nonadherence is associated with multiple negative outcomes. Financial
reinforcement based on behavioral economic principles has been proposed as a potential …

This study aimed to explore the relationship between knowledge about psychosis, insight,
and medication adherence among patients at an early stage of a schizophrenia-spectrum …

Non‐adherence to medication is highly prevalent in patients with schizophrenia. Adherence
therapy aims to improve medication adherence of these patients by applying techniques of …